Literature DB >> 16027241

Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone.

Ana Quênia Gomes da Silva1, Robson Augusto Sousa dos Santos, Marco Antônio Peliky Fontes.   

Abstract

In this study, we tested the hypothesis that angiotensin-(1-7) [Ang-(1-7)] acting in the neurons of paraventricular hypothalamic nucleus (PVN) contributes to the maintenance of sympathetic activity and blood pressure. For this purpose, the effects of microinjection of the A-779, the receptor Mas antagonist, into the PVN on mean arterial pressure (MAP), heart rate (HR), and renal sympathetic nerve activity (RSNA) were evaluated. In rats anesthetized with urethane (1.2 to 1.4 g/kg IP), bilateral microinjections of A-779 (0.1 nmol) into the PVN resulted in a selective and significant decrease in RSNA (-26+/-6% versus -2+/-3% vehicle; saline 0.9%). The magnitude of the decrease in RSNA produced by A-779 was comparable to that observed after microinjection of muscimol (1 nmol; -26+/-4%), a powerful neuronal inhibitor. A higher dose of A-779 (1 nmol) caused a reduction in RSNA (-21+/-4%) that was comparable in magnitude to the reduction observed with the lower dose. When compared with vehicle solution, no significant changes in MAP or HR were observed with both doses of A-779 tested. A decrease in RSNA was also observed after microinjections into the PVN of the angiotensin II type 2 (AT2) receptor antagonist PD123319 (1 nmol; -18+/-4%). Microinjections of the AT1 antagonist losartan but not CV 11974 reduced MAP without changing RSNA. These results suggest that Ang-(1-7) Mas receptors and AT2 receptors in the PVN neurons play a role in mediating the tonic maintenance of RSNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027241     DOI: 10.1161/01.HYP.0000179216.04357.49

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  26 in total

1.  Chronic infusion of angiotensin receptor antagonists in the hypothalamic paraventricular nucleus prevents hypertension in a rat model of sleep apnea.

Authors:  Ana Quenia Gomes da Silva; Marco Antônio Peliky Fontes; Nancy Lapp Kanagy
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

2.  (Pro)renin receptor knockdown in the paraventricular nucleus of the hypothalamus attenuates hypertension development and AT1 receptor-mediated calcium events.

Authors:  Lucas A C Souza; Caleb J Worker; Wencheng Li; Fatima Trebak; Trevor Watkins; Ariana Julia B Gayban; Evan Yamasaki; Silvana G Cooper; Bernard T Drumm; Yumei Feng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-03-29       Impact factor: 4.733

3.  Neuronal over-expression of ACE2 protects brain from ischemia-induced damage.

Authors:  Ji Chen; Yuhui Zhao; Shuzhen Chen; Jinju Wang; Xiang Xiao; Xiaotang Ma; Madhuri Penchikala; Huijing Xia; Eric Lazartigues; Bin Zhao; Yanfang Chen
Journal:  Neuropharmacology       Date:  2014-01-15       Impact factor: 5.250

4.  Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus.

Authors:  Jeffrey P Cardinale; Srinivas Sriramula; Nithya Mariappan; Deepmala Agarwal; Joseph Francis
Journal:  Hypertension       Date:  2011-11-21       Impact factor: 10.190

Review 5.  Angiotensin peptides and central autonomic regulation.

Authors:  Debra I Diz; Amy C Arnold; Manisha Nautiyal; Katsunori Isa; Hossam A Shaltout; E Ann Tallant
Journal:  Curr Opin Pharmacol       Date:  2011-02-28       Impact factor: 5.547

Review 6.  ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.

Authors:  Ping Xu; Srinivas Sriramula; Eric Lazartigues
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-22       Impact factor: 3.619

7.  Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.

Authors:  Hong Zheng; Xuefei Liu; Kaushik P Patel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-30       Impact factor: 4.733

Review 8.  Angiotensin II, sympathetic nerve activity and chronic heart failure.

Authors:  Yutang Wang; Sai-Wang Seto; Jonathan Golledge
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 9.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

10.  Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.

Authors:  Yumei Feng; Huijing Xia; Yanhui Cai; Carmen M Halabi; Lenice K Becker; Robson A S Santos; Robert C Speth; Curt D Sigmund; Eric Lazartigues
Journal:  Circ Res       Date:  2009-11-19       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.